Technical Analysis for MDSO - Medidata Solutions, Inc.

Grade Last Price % Change Price Change
grade B 89.27 -1.32% -1.19
MDSO closed down 1.32 percent on Monday, May 20, 2019, on 78 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Down
See historical MDSO trend table...

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction 0.00%
NR7 Range Contraction 0.00%
Multiple of Ten Bearish Other 0.00%
BB Squeeze Ended Range Expansion 0.00%
Fell Below 20 DMA Bearish -1.32%
Bollinger Band Squeeze Range Contraction -1.32%
Multiple of Ten Bullish Other -1.32%
BB Squeeze Started Range Contraction -1.32%
20 DMA Support Bullish -1.32%
Crossed Above 20 DMA Bullish -2.48%

Older signals for MDSO ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Medidata Solutions, Inc. provides cloud-based clinical development solutions for life sciences organizations in the United States and internationally. The company's solutions comprise software and services that allow customers to increase the value of their clinical development by designing, planning, and managing key aspects of the clinical trial process, including study and protocol design, trial planning and budgeting, site negotiation, clinical portal, trial management, randomization and trial supply management, clinical data capture and management, safety events capture, medical coding, clinical business analytics, and data flow and interoperability. It offers Medidata Rave, a platform for capturing and managing clinical data; Medidata CTMS, a clinical trial management solution that streamlines operational workflows; Medidata Designer, a study and protocol design tool that enhances the efficiency of clinical trial start-up; Medidata Insights, a business analytics platform; and Medidata Balance, a randomization and trial supply management solution. The company also provides Medidata Grants Manager, which enables to develop and manage trial budgets; Medidata contract research organization (CRO) Contractor, an analytical tool for CRO outsourcing, budgeting, and negotiation; and iMedidata, a hosted portal application that allows investigative sites and sponsor study teams to start trial activities. In addition, it offers hosting, support, and professional services. The company serves pharmaceutical, biotechnology, medical device, and diagnostics companies, as well as institutions, clinical research organizations, and other entities engaged in clinical trials. Medidata Solutions, Inc. markets and sells its application services through a direct sales force, as well as through relationships with CROs and other strategic partners. The company was founded in 1999 and is headquartered in New York, New York.
Biotechnology Health Pharmaceutical Industry Clinical Trial Clinical Research Medical Research Clinical Data Management Analytical Tool Contract Research Organization Medidata Solutions
Is MDSO a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 98.6
52 Week Low 60.1
Average Volume 870,406
200-Day Moving Average 75.3281
50-Day Moving Average 82.2044
20-Day Moving Average 90.998
10-Day Moving Average 91.147
Average True Range 3.3981
ADX 28.58
+DI 22.7715
-DI 17.0462
Chandelier Exit (Long, 3 ATRs ) 88.40569999999999
Chandelier Exit (Short, 3 ATRs ) 85.15429999999999
Upper Bollinger Band 94.3766
Lower Bollinger Band 87.6194
Percent B (%b) 0.24
BandWidth 7.425658
MACD Line 2.4692
MACD Signal Line 3.2585
MACD Histogram -0.7893
Fundamentals Value
Market Cap 5.05 Billion
Num Shares 56.6 Million
EPS 0.62
Price-to-Earnings (P/E) Ratio 143.98
Price-to-Sales 8.38
Price-to-Book 9.63
PEG Ratio 2.80
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 91.72
Resistance 3 (R3) 91.80 91.08 91.31
Resistance 2 (R2) 91.08 90.45 91.03 91.17
Resistance 1 (R1) 90.17 90.07 89.81 90.09 91.04
Pivot Point 89.45 89.45 89.27 89.40 89.45
Support 1 (S1) 88.54 88.82 88.18 88.46 87.50
Support 2 (S2) 87.82 88.44 87.77 87.37
Support 3 (S3) 86.91 87.82 87.23
Support 4 (S4) 86.83